Boston Scientific's Off-Label Stent Sales Probed
Boston Scientific Corp.'s annual report to the U.S. Securities and Exchange Commission said Thursday that the Department of Justice is investigating allegations that the company promoted its biliary stents for off-label...To view the full article, register now.
Already a subscriber? Click here to view full article